Skip to Content

View Additional Section Content

A Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT03233711?term=ea2165&rank=1

Clinical Trial Categories

  • Colorectal Cancer
Contact
Carolann Twelves, RN at 215-481-4149

Location

  • Asplundh Cancer Pavilion
    3941 Commerce Ave.
    Willow Grove, PA 19090

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM